These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21704501)

  • 41. Do motivation deficits in schizophrenia-spectrum disorders promote cannabis use? An investigation of behavioural response to natural rewards and drug cues.
    Cassidy CM; Lepage M; Malla A
    Psychiatry Res; 2014 Mar; 215(3):522-7. PubMed ID: 24398065
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lifetime positive symptoms in patients with schizophrenia and cannabis abuse are partially explained by co-morbid addiction.
    Dubertret C; Bidard I; Adès J; Gorwood P
    Schizophr Res; 2006 Sep; 86(1-3):284-90. PubMed ID: 16806837
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Motivational changes of cannabis use prior to and during the course of schizophrenia.
    Schnell T; Gliese R; Schröter R; Kasten E; Gouzoulis-Mayfrank E
    Am J Addict; 2017 Mar; 26(2):122-128. PubMed ID: 28004866
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Memory Impairment in HIV-Infected Individuals with Early and Late Initiation of Regular Marijuana Use.
    Skalski LM; Towe SL; Sikkema KJ; Meade CS
    AIDS Behav; 2018 May; 22(5):1596-1605. PubMed ID: 28884250
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.
    Korver N; Nieman DH; Becker HE; van de Fliert JR; Dingemans PH; de Haan L; Spiering M; Schmitz N; Linszen DH
    Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neurocognitive functioning of individuals with schizophrenia: using and not using drugs.
    Bahorik AL; Newhill CE; Eack SM
    Schizophr Bull; 2014 Jul; 40(4):856-67. PubMed ID: 23884348
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Study of the Impact of Cannabis on Doses of Discharge Antipsychotic Medication in Individuals with Schizophrenia or Schizoaffective Disorder.
    Babatope T; Chotalia J; Elkhatib R; Mohite S; Shah J; Goddu S; Patel RA; Aimienwanu OR; Patel D; Makanjuola T; Okusaga OO
    Psychiatr Q; 2016 Dec; 87(4):729-737. PubMed ID: 26875104
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample.
    Yücel M; Bora E; Lubman DI; Solowij N; Brewer WJ; Cotton SM; Conus P; Takagi MJ; Fornito A; Wood SJ; McGorry PD; Pantelis C
    Schizophr Bull; 2012 Mar; 38(2):316-30. PubMed ID: 20660494
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings.
    Meijer JH; Dekker N; Koeter MW; Quee PJ; van Beveren NJ; Meijer CJ;
    Psychol Med; 2012 Apr; 42(4):705-16. PubMed ID: 21899795
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The influence of neurocognitive deficits and symptoms on disability in schizophrenia.
    Ertuğrul A; Uluğ B
    Acta Psychiatr Scand; 2002 Mar; 105(3):196-201. PubMed ID: 11939973
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Cannabis and schizophrenia: demographic and clinical correlates].
    Dervaux A; Laqueille X; Bourdel MC; Leborgne MH; Olié JP; Lôo H; Krebs MO
    Encephale; 2003; 29(1):11-7. PubMed ID: 12640322
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Perspectives of cannabis use in the life experience of men with schizophrenia.
    Wagstaff C; Graham H; Farrell D; Larkin M; Tatham L
    Int J Ment Health Nurs; 2018 Jun; 27(3):1099-1108. PubMed ID: 29218823
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neurocognitive Impairments in Deficit and Non-Deficit Schizophrenia and Their Relationships with Symptom Dimensions and Other Clinical Variables.
    Yu M; Tang X; Wang X; Zhang X; Zhang X; Sha W; Yao S; Shu N; Zhang X; Zhang Z
    PLoS One; 2015; 10(9):e0138357. PubMed ID: 26381645
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential effects of childhood trauma and cannabis use disorders in patients suffering from schizophrenia.
    Baudin G; Godin O; Lajnef M; Aouizerate B; Berna F; Brunel L; Capdevielle D; Chereau I; Dorey JM; Dubertret C; Dubreucq J; Faget C; Fond G; Gabayet F; Laouamri H; Lancon C; Le Strat Y; Tronche AM; Misdrahi D; Rey R; Passerieux C; Schandrin A; Urbach M; Vidalhet P; Llorca PM; Schürhoff F;
    Schizophr Res; 2016 Aug; 175(1-3):161-167. PubMed ID: 27209524
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A preliminary comparison of cannabis use in subsyndromal gamblers: select neurocognitive and behavioral differences based on use.
    Leppink E; Derbyshire K; Chamberlain SR; Grant JE
    J Addict Med; 2014; 8(6):443-9. PubMed ID: 25303983
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Psychoactive Substance Use by Adults With Schizophrenia Before and During Cannabis Withdrawal.
    Koola MM; Kelly DL; McMahon RP; Boggs DL; Liu F; Gorelick DA
    Prim Care Companion CNS Disord; 2016 Sep; 18(5):. PubMed ID: 27835727
    [No Abstract]   [Full Text] [Related]  

  • 57. Schizophrenia in users and nonusers of cannabis. A longitudinal study in Stockholm County.
    Andréasson S; Allebeck P; Rydberg U
    Acta Psychiatr Scand; 1989 May; 79(5):505-10. PubMed ID: 2787581
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relationship between cannabis use, schizotypal traits, and cognitive function in healthy subjects.
    Mass R; Bardong C; Kindl K; Dahme B
    Psychopathology; 2001; 34(4):209-14. PubMed ID: 11549932
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of cannabis in cognitive functioning of patients with schizophrenia.
    Schnell T; Koethe D; Daumann J; Gouzoulis-Mayfrank E
    Psychopharmacology (Berl); 2009 Jul; 205(1):45-52. PubMed ID: 19326102
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions.
    Crean RD; Crane NA; Mason BJ
    J Addict Med; 2011 Mar; 5(1):1-8. PubMed ID: 21321675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.